Amygdala Neurosciences

Amygdala Neurosciences is an independent small biopharmaceutical company founded in 2015. Its mission is to address the growing unmet needs associated with alcohol use disorder (AUD) and other substance use disorders (SUD) by discovering, developing, and commercializing safe and effective drug therapies to treat addiction. The company is developing orally administrable drugs to suppress cravings and relapses associated with alcohol and other substance use disorders.